Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-kappaB and Akt signaling pathways in renal cancer cells

Journal of Cellular Biochemistry
Tae-Jin LeeTaeg-Kyu Kwon

Abstract

The prostate-apoptosis-response-gene-4 (Par-4) is up-regulated in prostate cells undergoing programmed cell death. Furthermore, Par-4 protein has been shown to function as an effector of cell death in response to various apoptotic stimuli that trigger mitochondria and membrane receptor-mediated cell death pathways. In this study, we investigated how Par-4 modulates TRAIL-mediated apoptosis in TRAIL-resistant Caki cells. Par-4 overexpressing cells were strikingly sensitive to apoptosis induced by TRAIL compared with control cells. Par-4 overexpressing Caki cells treated with TRAIL showed an increased activation of the initiator caspase-8 and the effector caspase-3, together with an enforced cleavage of XIAP and c-FLIP. TRAIL-induced reduction of XIAP and c-FLIP protein levels in Par-4 overexpressing cells was prevented by z-VAD pretreatment. In addition, the surface DR5 protein level was increased in TRAIL-treated Par-4 overexpressing cells. Interestingly, even though a deletion of leucine zipper domain in Par-4 recovered Bcl-2 level to basal level induced by wild type Par-4, it partly decreased sensitivity to TRAIL in Caki cells. In addition, exposure of Caki/Par-4 cells to TRAIL led to reduction of phosphorylated Akt levels, b...Continue Reading

References

May 31, 1996·The Journal of Biological Chemistry·R M PittiA Ashkenazi
Jul 1, 1997·Molecular and Cellular Biology·S F SellsV M Rangnekar
Jul 17, 1997·Nature·Q L DeverauxJ C Reed
Jun 28, 2002·Cancer Metastasis Reviews·S GurumurthyV M Rangnekar
Dec 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Julie GuillermetCorinne Bousquet
Feb 5, 2003·Experimental Cell Research·Nadia El-Guendy, Vivek M Rangnekar
Apr 16, 2003·Cell Cycle·Jorge Moscat, Maria T Diaz-Meco
Jun 6, 2003·Cytokine & Growth Factor Reviews·Alexandru Almasan, Avi Ashkenazi
Aug 5, 2003·Molecular and Cellular Biology·Nadia El-GuendyVivek M Rangnekar
Aug 19, 2004·Annals of Hematology·Marion BergmannSimone Boehrer
Oct 12, 2004·The Journal of Biological Chemistry·Ying-Yu WuMing-Zong Lai
Jan 20, 2005·Molecular and Cellular Biology·Sushma GurumurthyVivek M Rangnekar
Mar 24, 2005·Journal of Cellular and Molecular Medicine·Gang SongShideng Bao
Oct 8, 2005·Molecular Cell·Anindya GoswamiVivek M Rangnekar
Mar 4, 2006·Leukemia Research·Simone BoehrerKai Uwe Chow
Mar 17, 2006·Cancer Research·Anindya GoswamiVivek M Rangnekar
Sep 21, 2006·Molecular Cancer Therapeutics·Sanaz KhanbolookiDavid J McConkey
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mitchell R SmithIndira Joshi
Jul 25, 2008·The EMBO Journal·Jayashree JoshiMaria T Diaz-Meco
Jul 28, 2009·Cell·Ravshan BurikhanovVivek M Rangnekar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.